Open AccessLaboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018
Author(s) -
Stacey Hong,
Papanin Putsathit,
Narelle George,
Christine Hemphill,
Peter G. Huntington,
Tony M. Korman,
Despina Kotsanas,
Monica M Lahra,
Rodney McDougall,
Casey V. Moore,
Graeme R. Nimmo,
Louise Prendergast,
Jennifer Robson,
Lynette Waring,
Michael C Wehrhahn,
Gerhard F. Weldhagen,
Richard Wilson,
Thomas V. Riley,
Daniel Knight
Publication year - 2020
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01552-20
Subject(s) - clostridium difficile , outbreak , microbiology and biotechnology , infection control , epidemiology , disease surveillance , clostridium difficile toxin a , medicine , biology , virology , intensive care medicine , antibiotics
In the early 2000s, a binary toxin (CDT)-producing strain ofClostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. TheC. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study ofC. difficile infection (CDI) in Australia.